Third-generation chimeric antigen receptor (CAR) T cells in patients with lymphoid disease - results of the Heidelberg trial 1 (HD-CAR-1 trial)

被引：0
|
作者：
Schubert, M. L. [1 ]
Schmitt, A. [1 ]
Neuber, B. [1 ]
Hueckelhoven-Krauss, A. [1 ]
Kunz, A. [1 ]
Wang, L. [1 ]
Michels, B. [1 ]
Waldhoff, P. [1 ]
Sellner, L. [1 ,2 ]
Korell, F. [1 ]
Hofmann, S. [1 ]
Pavel, P. [3 ]
Ho, A. D. [1 ,2 ]
Mueller-Tidow, C. [1 ,2 ]
Dreger, P. [1 ,2 ]
Schmitt, M. [1 ,2 ]
机构：
[1] Univ Klinikum Heidelberg, Innere Med 5, Heidelberg, Germany
[2] Deutsch Krebsforschungszentrum DKFZ, Deutsch Konsortium Translat Krebsforsch DKTK, Natl Ctr Tumorerkrankungen NCT, Heidelberg, Germany
[3] DRK Blutspendedienst Baden Wurttemberg Hessen, Inst Klin Transfus Med & Zelltherapie IKTZ, Heidelberg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2021年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V318
引用
收藏
页码：122 / 123
页数：2
相关论文
共 50 条
  • [31] Effect of chimeric antigen receptor (CAR) T cells on clonal expansion of endogenous non-CAR T cells in patients (pts) with advanced solid cancer.
    Kim, Rebecca H.
    Plesa, Gabriela
    Gladney, Whitney
    Kulikovskaya, Irina
    Levine, Bruce L.
    Lacey, Simon F.
    June, Carl H.
    Melenhorst, Jan J.
    Beatty, Gregory Lawrence
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [32] EXPLOITING THE DNAM-1 SYSTEM FOR CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL THERAPY OF GLIOBLASTOMA
    Weiss, T.
    Meister, H.
    Weller, M.
    Sentman, C.
    Roth, P.
    NEURO-ONCOLOGY, 2019, 21 : 2 - 2
  • [33] Optimization of Third Generation Chimeric Antigen Receptor T Cells Targeting ROR1 for Hematological Malignancies
    Cortes, Eider F. Moreno
    Robledo, Juan Esteban Garcia
    Booth, Natalie
    Forero, Jose V.
    Castro, Januario E.
    BLOOD, 2021, 138
  • [34] Therapeutic potential of third-generation chimeric antigen receptor T cells targeting B cell maturation antigen for treating multiple myeloma
    Rujirachaivej, Punchita
    Siriboonpiputtana, Teerapong
    Luangwattananun, Piriya
    Yuti, Pornpimon
    Wutti-in, Yupanun
    Choomee, Kornkan
    Sujjitjoon, Jatuporn
    Chareonsirisuthigul, Takol
    Rerkamnuaychoke, Budsaba
    Junking, Mutita
    Yenchitsomanus, Pa-thai
    CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 24 (01)
  • [35] Direct Comparison of In Vivo Fate of Second and Third-Generation CD19-Specific Chimeric Antigen Receptor (CAR)-T Cells in Patients with B-Cell Lymphoma: Reversal of Toxicity from Tonic Signaling
    da Silva, Diogo Gomes
    Mukherjee, Malini
    Srinivasan, Madhuwanti
    Dakhova, Olga
    Liu, Hao
    Grilley, Bambi
    Gee, Adrian P.
    Neelapu, Sattva S.
    Rooney, Cliona M.
    Heslop, Helen E.
    Savoldo, Barbara
    Dotti, Gianpietro
    Brenner, Malcolm K.
    Mamonkin, Maksim
    Ramos, Carlos A.
    BLOOD, 2016, 128 (22)
  • [36] Therapy for folate receptor 1 (FOLR1) positive gastric cancer using chimeric antigen receptor (CAR) T cell
    Park, C. H.
    Kim, M.
    Choi, S. U.
    FEBS JOURNAL, 2017, 284 : 266 - 266
  • [37] ANTI-NUCLEOLIN CAR (CHIMERIC ANTIGEN RECEPTOR)-T CELL TARGETING TRIPLE-NEGATIVE BREAST CANCER - CRITICAL PARAMETERS IN CAR-T CELLS GENERATION
    Abreu, T. R.
    Godinho-Santos, A.
    Moreira, J. N.
    Goncalves, J.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A23 - A23
  • [38] Image-guided interventional radiological delivery of chimeric antigen receptor (CAR) T cells for pleural malignancies in a phase I/II clinical trial
    Ghosn, Mario
    Cheema, Waseem
    Zhu, Amy
    Livschitz, Jennifer
    Maybody, Majid
    Boas, Franz E.
    Santos, Ernesto
    Kim, DaeHee
    Beattie, Jason A.
    Offin, Michael
    Rusch, Valerie W.
    Zauderer, Marjorie G.
    Adusumilli, Prasad S.
    Solomon, Stephen B.
    LUNG CANCER, 2022, 165 : 1 - 9
  • [39] A simple and effective method to purify and activate T cells for successful generation of chimeric antigen receptor T (CAR-T) cells from patients with high monocyte count
    Haiying Wang
    Shih-Ting Tsao
    Mingyuan Gu
    Chengbing Fu
    Feng He
    Xiu Li
    Mian Zhang
    Na Li
    Hong-Ming Hu
    Journal of Translational Medicine, 20
  • [40] Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results
    Qi, Changsong
    Gong, Jifang
    Li, Jian
    Liu, Dan
    Qin, Yanru
    Ge, Sai
    Zhang, Miao
    Peng, Zhi
    Zhou, Jun
    Cao, Yanshuo
    Zhang, Xiaotian
    Lu, Zhihao
    Lu, Ming
    Yuan, Jiajia
    Wang, Zhenghang
    Wang, Yakun
    Peng, Xiaohui
    Gao, Huiping
    Liu, Zhen
    Wang, Huamao
    Yuan, Daijing
    Xiao, Jun
    Ma, Hong
    Wang, Wei
    Li, Zonghai
    Shen, Lin
    NATURE MEDICINE, 2022, 28 (06) : 1189 - +
12345